INIMMUNE
Inimmune is focused on the discovery and development of novel immunotherapeutics for an array of disease areas. Inimmune technology is focused on the discovery, optimization, and development of new innate immune receptor agonists and antagonists to treat a wide array of medical conditions including allergy, autoimmune diseases, and cancer. It was founded in 2016 and based in Missoula, Montana.
INIMMUNE
Industry:
Biotechnology Health Care
Founded:
2016-01-01
Address:
Missoula, Montana, United States
Country:
United States
Website Url:
http://www.inimmune.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
22.59 M USD
Technology used in webpage:
SPF Google Font API LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail ReCAPTCHA JsDelivr Microsoft Azure DNS
Similar Organizations
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Current Advisors List
Current Employees Featured
Founder
Investors List
Two Bear Capital
Two Bear Capital investment in Series A - Inimmune
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - Inimmune
Official Site Inspections
http://www.inimmune.com Semrush global rank: 5.74 M Semrush visits lastest month: 1.46 K
- Host name: s1058.use1.mysecurecloudhost.com
- IP address: 65.181.111.163
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Inimmune"
About - Inimmune
Inimmune was founded in early 2016 by Drs. Jay Evans, David Burkhart, Helene Bazin-Lee, Kendal Ryter, and a team of 11 highly trained scientists. This team of chemists, immunologists, and formulation scientists have been at the cutting …See details»
Investors - Inimmune
Corporate Overview Inimmune is a clinical-stage innovative biotech company focused on the discovery and development of novel, disruptive immunotherapies for allergy, cancer, infectious …See details»
Inimmune - Crunchbase Company Profile & Funding
Inimmune is focused on the discovery and development of novel immunotherapeutics for an array of disease areas. Inimmune technology is focused on the discovery, optimization, and development of new innate …See details»
Inimmune - LinkedIn
About Inimmune Corporation Inimmune Corp. (Missoula, MT) is a privately held biotechnology company focused on the discovery and development of innovative immunotherapeutics, adjuvants, and vaccines.See details»
Inimmune Company Profile 2024: Valuation, Funding & Investors
Inimmune General Information Description. Operator of a biotechnology company intended to offer treatment for allergy, autoimmunity, and cancer in patients. The company focuses on the …See details»
Inimmune Corporation - VentureRadar
Inimmune is working to create new immunotherapies directed at making meaningful and lasting clinical impacts in the areas of allergy, autoimmunity, infectious disease and cancer. Through …See details»
Inimmune Company Profile - Office Locations, Competitors ... - Craft
Inimmune has 5 employees at their 1 location and $22.59 m in total funding,. See insights on Inimmune including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Inimmune - Contacts, Employees, Board Members, Advisors
Organization. Inimmune . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board …See details»
Inimmune Corporation - BIO International Convention | BIO
Jun 5, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Inimmune …See details»
Leadership - Inimmune
Management Team Board of Directors Scientific Advisory BoardSee details»
Inimmune raises $22 million for innate immune system drug …
Jul 18, 2020 Inimmune, a Montana-based start-up, has raised $22 million in series A funding to develop compounds that stimulate the innate immune system. Founded in 2016 by chemists, …See details»
Inimmune Corporation and Intrommune Therapeutics announce a ...
Jan 8, 2024 MISSOULA, Mont. and NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Inimmune Corporation (“Inimmune”) and Intrommune Therapeutics, Inc. (“Intrommune”), …See details»
Inimmune Corporation announces First Subject Dosed in First-in …
Aug 2, 2023 "We already have in place an Australian subsidiary, an experienced phase 1 clinical site, and a relationship with a well-respected local contract research organization." Inimmune …See details»
Working at Inimmune - Glassdoor
Inimmune was formed from an experienced, close-knit team of biotech/pharmaceutical industry professionals. This team of chemists, immunologists and formulation scientists have been at …See details»
Contact - Inimmune
Contact Us Please contact us with any inquiries. Office 1121 E Broadway St, Ste 106, Missoula, MT, 59802 Email [email protected] Phone (406) 541-5913See details»
Inimmune Corporation announces First Subject Dosed in First-in …
Aug 2, 2023 Inimmune Corp. (Missoula, MT) is a privately held biotechnology company focused on the discovery and development of innovative immunotherapeutics, vaccine adjuvants, and …See details»
Inimmune | Missoula MT - Facebook
Inimmune, Missoula, Montana. 103 likes · 3 were here. Inimmue is a biotechnology company founded by pharmaceutical industry veterans focused on developing next generation …See details»
Pipeline - Inimmune
Our Pipeline: Innate Immune Modulators Our vision is to develop novel, safe, and effective immunotherapies for the treatment and prevention of cancer, allergy, infectious disease, and …See details»
News - Inimmune
Latest News The latest in our partnerships, collaborations, company updates, and milestones. Select Year 2024 2023 2022 2021 2020 2019 Select Year Most Recent Oldest Press Release …See details»